相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
Genetic mechanisms of critical illness in COVID-19
Erola Pairo-Castineira et al.
NATURE (2021)
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler et al.
CELL (2021)
Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication
Yue Ma-Lauer et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Yixuan J. Hou et al.
CELL (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model
Hua-Hao Fan et al.
CHINESE MEDICAL JOURNAL (2020)
IL-6: Relevance for immunopathology of SARS-CoV-2
E. O. Gubernatorova et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
Shutoku Matsuyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
Michelle Willicombe et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 Pandemic: Time to Revive the Cyclophilin Inhibitor Alisporivir
Jean-Michel Pawlotsky
CLINICAL INFECTIOUS DISEASES (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ongoing Clinical Trials for the Management of the COVID-19 Pandemic
Mark P. Lythgoe et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2020)
Potential Antiviral Options against SARS-CoV-2 Infection
Aleksandr Ianevski et al.
VIRUSES-BASEL (2020)
Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements
Abhjieet Pandey et al.
LIFE SCIENCES (2020)
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
Pablo Guisado-Vasco et al.
ECLINICALMEDICINE (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
Jennifer Harcourt et al.
EMERGING INFECTIOUS DISEASES (2020)
Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19
Naidi Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells
Yunsheng Zhang et al.
BMC CANCER (2019)
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
Masashi Iwamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
Christian Bailly
PHYTOMEDICINE (2019)
Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells
Anjali Jacob et al.
NATURE PROTOCOLS (2019)
Targeting the Ca2+/Calmodulin-dependent protein kinase II by Tetrandrine in human liver cancer cells
Tracy Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells
Dong Eon Kim et al.
BIOMOLECULES (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Salinomycin, as an autophagy modulator-a new avenue to anticancer: a review
Jiang Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells
Jean Kaoru Millet et al.
VIROLOGY (2018)
Epidermal growth factor receptor is a co-factor for transmissible gastroenteritis virus entry
Weiwei Hu et al.
VIROLOGY (2018)
Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function
Yejin Jang et al.
JOURNAL OF VIROLOGY (2018)
Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B
Yoshikazu Tanaka et al.
JOURNAL OF GENERAL VIROLOGY (2017)
Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus
Keiko Rausch et al.
CELL REPORTS (2017)
Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses
Laurent Meertens et al.
CELL REPORTS (2017)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment
Yasuteru Sakurai et al.
SCIENCE (2015)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication
Albrecht von Brunn et al.
CURRENT OPINION IN VIROLOGY (2015)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Cyclophilin inhibition as potential therapy for liver diseases
Nikolai V. Naoumov
JOURNAL OF HEPATOLOGY (2014)
Viruses exploit the function of epidermal growth factor receptor
Kai Zheng et al.
REVIEWS IN MEDICAL VIROLOGY (2014)
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
Javier Carbajo-Lozoya et al.
VIRUS RESEARCH (2014)
A New Phenylpyrazoleanilide, Y-320, Inhibits Interleukin 17 Production and Ameliorates Collagen-Induced Arthritis in Mice and Cynomolgus Monkeys
Hiroyuki Ushio et al.
PHARMACEUTICALS (2014)
Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: Differences between primary and cancer cells
Jaganmohan Reddy Jangamreddy et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment
Adriaan H. de Wilde et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486
Bridget M. Dolan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cyclophilin A and viral infections
Daijun Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Hepatocytes That Express Variants of Cyclophilin A Are Resistant to HCV Infection and Replication
Thomas von Hahn et al.
GASTROENTEROLOGY (2012)
Severe Acute Respiratory Syndrome Coronavirus Replication Is Severely Impaired by MG132 due to Proteasome-Independent Inhibition of M-Calpain
Martha Schneider et al.
JOURNAL OF VIROLOGY (2012)
Hepatitis C Virus Induces Epidermal Growth Factor Receptor Activation via CD81 Binding for Viral Internalization and Entry
Jingyu Diao et al.
JOURNAL OF VIROLOGY (2012)
Cyclophilin A Restricts Influenza A Virus Replication through Degradation of the M1 Protein
Xiaoling Liu et al.
PLOS ONE (2012)
Cyclosporin A Inhibits the Influenza Virus Replication through Cyclophilin A-Dependent and -Independent Pathways
Xiaoling Liu et al.
PLOS ONE (2012)
Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species
Berlinda Verdoodt et al.
PLOS ONE (2012)
Cyclosporin A inhibits the replication of diverse coronaviruses
Adriaan H. de Wilde et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
Ilona Glowacka et al.
JOURNAL OF VIROLOGY (2011)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
Hepatitis B Virus (HBV) Surface Antigen Interacts with and Promotes Cyclophilin A Secretion: Possible Link to Pathogenesis of HBV Infection
Xiaochen Tian et al.
JOURNAL OF VIROLOGY (2010)
An emerging role for p21-activated kinases (Paks) in viral infections
Celine Van den Broeke et al.
TRENDS IN CELL BIOLOGY (2010)
The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells
Thorsten Eierhoff et al.
PLOS PATHOGENS (2010)
Histamine H1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases
T. Okamoto et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors
Yu Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
Sandrine Belouzard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Differential effects of triptolide and tetrandrine on activation of COX-2, NF-κB, and AP-1 and virus production in dengue virus-infected human lung cells
Jun-Ting Liou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro
Feng Yang et al.
JOURNAL OF VIROLOGY (2008)
The mechanism of axl-mediated Ebola virus infection
Masayuki Shimojima et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus
SR Weiss et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2005)
A standard curve based method for relative real time PCR data processing
A Larionov et al.
BMC BIOINFORMATICS (2005)
The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry
GY Yu et al.
JOURNAL OF VIROLOGY (2005)
A new cell-permeable peptide allows successful allogeneic islet transplantation in mice
H Noguchi et al.
NATURE MEDICINE (2004)
Cellular entry of the SARS coronavirus
H Hofmann et al.
TRENDS IN MICROBIOLOGY (2004)
A review of the second-generation antihistamine ebastine for the treatment of allergic disorders
P Van Cauwenberge et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Transcriptional regulation by calcium, calcineurin, and NFAT
PG Hogan et al.
GENES & DEVELOPMENT (2003)
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
GJ Towers et al.
NATURE MEDICINE (2003)
Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles
APV Castro et al.
JOURNAL OF VIROLOGY (2003)
Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype
S Bose et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines
M Nori et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication
KJ Blight et al.
JOURNAL OF VIROLOGY (2002)
Determination of preferential binding sites for anti-dsRNA antibodies on double-stranded RNA by scanning force microscopy
M Bonin et al.
RNA (2000)
分享论文
